{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-027976","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2026-06-09T21:16:50+00:00","discovered_at":"2026-06-09T21:18:00.285992+00:00","generated_at":"2026-06-09T21:18:16.022592+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Enveric Biosciences upsizes ATM offering by $2.425M; prior sales total $4.48M","bullets":["Filed prospectus supplement to sell up to $2,425,000 of common stock under existing ATM agreement.","Prior ATM sales through H.C. Wainwright totaled $4,483,711.04.","Legal opinion from Greenberg Traurig filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-027976","json":"https://secwatch.observer/filing/0001493152-26-027976.json","markdown":"https://secwatch.observer/filing/0001493152-26-027976.md","text":"https://secwatch.observer/filing/0001493152-26-027976.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315226027976/0001493152-26-027976-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315226027976/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T21:18:16.022592+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}